Please select the option that best describes you:

For optimal GDMT for patients with HFrEF and co-existing ESRD, is there evidence to support the use of SGLT2 inhibitors and/or ARB/ARNI?  



Answer from: at Academic Institution
Comments
at Novolink Medical Group. High Risk Category
In my experience,  with very careful monitori...
Sign in or Register to read more